Cited by 61Protein Kinase Regulation and GTPase SignalingProtein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancer

Activation of Phospholipase Cγ2 by Tyrosine Phosphorylation

Özdener, Fatih, Dangelmaier, Carol, Ashby, Barrie, Kunapuli, Satya P., Daniel, James L.·2002·Molecular Pharmacology

Abstract

Phospholipase Cgamma2 (PLCgamma2) has been implicated in collagen-induced signal transduction in platelets and antigen-dependent signaling in B-lymphocytes. It has been suggested that tyrosine kinases activate PLCgamma2. We expressed the full-length cDNA for human PLCgamma2 in bacteria and purified the recombinant enzyme. The recombinant enzyme was Ca(2+)-dependent with optimal activity in the range of 1 to 10 microM Ca(2+). In vitro phosphorylation experiments with recombinant PLCgamma2 and recombinant Lck, Fyn, and Lyn tyrosine kinases showed that phosphorylation of PLCgamma2 led to activation of the recombinant enzyme. Using site-directed mutagenesis, we investigated the role of specific tyrosine residues in activation of PLCgamma2. A mutant form of PLCgamma2, in which all three tyrosines at positions 743, 753, and 759 in the SH2-SH3 linker region were replaced by phenylalanines, exhibited decreased Lck-induced phosphorylation and completely abolished the Lck-dependent activation of PLCgamma2. Individual mutations of these tyrosine residues demonstrated that tyrosines 753 and 759, but not 743, were responsible for Lck-induced activation of PLCgamma2. To confirm these results, we procured a phosphospecific antibody to a peptide containing phosphorylated tyrosines corresponding to residues 753 and 759. This antibody recognized phosphorylated wild-type PLCgamma2 on Western blots but did not interact with unphosphorylated PLCgamma2 or with PLCgamma2 containing mutated tyrosine…

Integrity signals

Registry

Crossref · 10.1124/mol.62.3.672

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 37 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Özdener, F., Dangelmaier, C., Ashby, B., Kunapuli, S. P., & Daniel, J. L.
Affiliations
Temple University (US)
Venue
Molecular Pharmacology
Publisher
Elsevier BV
Published
2002-09
Volume
62
Issue
3
Pages
672-679
ISSN
0026-895X (ISSN-L)
OpenAlex
W1829376516
Cited by
60
References
37
Citations by year
2025: 1 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
FWCI
1.86
Type
journal article
Language
en
Open access
closed
Locations
  • Molecular Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL-60683, R01HL060683)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
PLCγ2, tyrosine phosphorylation, tyrosine kinase activation, Lck, Fyn, Lyn kinase, platelets, phospho-specific antibodies, calcium-dependent enzyme activity
MeSH terms
Blood Platelets, Enzyme Activation, Humans, Isoenzymes, Type C Phospholipases, Phosphorylation, Proto-Oncogene Proteins, Recombinant Proteins, Tyrosine, Mutagenesis, Site-Directed, src Homology Domains, src-Family Kinases, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Proto-Oncogene Proteins c-fyn, Phospholipase C gamma, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review